Related Experiment Videos
Trousseau's syndrome
1University of Louisville School of Medicine, Kentucky.
American Family Physician
|September 1, 1988
Summary
Trousseau's syndrome, a cancer-associated coagulopathy, presents with varied symptoms and often hidden cancers. Heparin is the preferred treatment, while warfarin shows no benefit for managing this condition.
Area of Science:
- Oncology
- Hematology
- Internal Medicine
Background:
- Trousseau's syndrome is a rare but serious manifestation of malignancy.
- It involves abnormal blood clotting linked to an underlying, often undetected, cancer.
Observation:
- The syndrome presents with a wide range of signs and symptoms.
- The primary cancer responsible for the coagulopathy is frequently occult, posing diagnostic challenges.
Findings:
- Treatment approaches for Trousseau's syndrome are diverse.
- Heparin is identified as the initial drug of choice, suitable for long-term outpatient management.
- Warfarin has not demonstrated efficacy in treating this condition.
Implications:
- Early recognition of Trousseau's syndrome is crucial for identifying occult malignancies.
- Effective management strategies, particularly the use of heparin, can improve patient outcomes.
- Further research may elucidate optimal treatment protocols for cancer-associated coagulopathy.